A Randomized, Double-Blind, Placebo-Controlled, Sequential, Ascending Single and Multiple Dose, Safety, Tolerability, and Pharmacokinetic Study of TAK-070 in Healthy Elderly Subjects
Latest Information Update: 17 May 2016
At a glance
- Drugs TAK 070 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 28 Feb 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 16 Mar 2013 New trial record